FDA Inspection 852213 — PCI Pharma Services Canada, Inc.
The FDA completed an inspection of PCI Pharma Services Canada, Inc. on September 25, 2013 in Mississauga. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 25, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Mississauga (Canada)